NCT05058144

Novel Alpha-Glucan Metabolism

Randomised, Placebo-controlled and Acute Study to Investigate the Metabolism of a Novel Alpha-Glucan in Adults

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 15 (actual)
• Sponsor: Société des Produits Nestlé (SPN) · Industry
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

These are the characteristics of the project: Monocentric: Double blind randomized and crossover: you will test all the 3 products in random order.

Detailed description

This study will be randomized, double blind, placebo-controlled, single-center, and 3x3 crossover in design. Eligible participants will be randomized to receive the below products in single dose and in different random sequence, as determined by the randomization system 1. 50 g novel alpha glucan 2. 50 g (rapidly digestible control) 3. 15 g (dietary fiber)

Conditions

• Healthy Volunteers

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Drinkable solution	the volunteer will consume the volume 300 ml of water with

Timeline

• Start date: 2021-08-30
• Primary completion: 2021-11-03
• Completion: 2022-01-30
• First posted: 2021-09-27
• Last updated: 2022-10-14

Locations

1 site across 1 country: Switzerland